infusion Drug class Antineoplastic agent ATC code L01FD03 (WHO ) Legal status Legal status AU... specifically for treatment of HER2-positive metastatic breast cancer (mBC) in patients who...
A drug called ribociclib, currently used to treat breast cancer, could prove to be an effective weapon against pediatric high-grade glioma, an aggressive childhood brain cancer, a new study says.
triple negative or basal like ; have lower levels of hormone receptors ; diagnosed at a later stage ; radiation therapy ; people with a BRCA1 mutation ; more aggressive
The new type of drug combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.
New research has revealed that the breast cancer drug alpelisib could have a major impact on... beneficial for some breast cancer patients. "The key benefit for breast cancer patients is...
Scientists will soon begin testing a new drug for its potential to treat triple-negative breast cancer
Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they ha...
When is chemotherapy used for breast cancer? ; Not all women with breast cancer will need chemo, but there are several situations in which chemo may be recommended. Adjuvant chemo might be given to try to kill any cancer cells that might have been left behind or have spread but can't be seen, even on imaging tests. These cells are considered microscopic because they can’t be seen by the naked eye. If these cells were allowed to grow, they could form new tumors in other places in the body. Adju...
Once they reach these sites, new cancer-related symptoms such as bone pain or headaches may appear. Treatment for breast cancer depends on the subtype of cancer and how much it has spread...
By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.